Loading...
Loading...
India's heparin imports from CANADA total $568 across 3 shipments from 1 foreign suppliers. STERIMAX INC leads with $568 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BIOLOGICAL E. LIMITED. This corridor reflects India's pharmaceutical import demand for heparin โ a concentrated sourcing relationship with select suppliers from CANADA.

STERIMAX INC is the leading Heparin supplier from CANADA to India, with import value of $568 across 3 shipments. The top 5 suppliers โ STERIMAX INC โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STERIMAX INC | $568 | 3 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOLOGICAL E. LIMITED | $568 | 3 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Heparin suppliers from CANADA to India include STERIMAX INC. The leading supplier is STERIMAX INC with import value of $568 USD across 3 shipments. India imported Heparin worth $568 USD from CANADA in total across 3 shipments.
India imported Heparin worth $568 USD from CANADA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Heparin sourced from CANADA include BIOLOGICAL E. LIMITED. The largest buyer is BIOLOGICAL E. LIMITED with $568 in imports across 3 shipments.
The total value of Heparin imports from CANADA to India is $568 USD, across 3 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists